News

Morgan Stanley Reaffirms Overweight on Gilead Sciences, Inc. (GILD), Citing LEN Potential
On Monday, analysts at Morgan Stanley reiterated their Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD), while ...
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...
MedPage Today on MSN21h
AKT Combination Increased PFS in Metastatic HR-Positive/HER2-Negative Breast Cancer
Median PFS increased from 1.94 months with single-agent fulvestrant to 5.32 months with the addition of ipatasertib. Patients ...
Psychiatry Advisor21h
Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States.
MedPage Today on MSN21h
Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLC
Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with chemotherapy ...
Pharmabiz22h
TWN calls for urgent need of stronger scrutiny in granting patents to avoid evergreening
TWN calls for urgent need of stronger scrutiny in granting patents to avoid evergreening: Our Bureau, New Delhi Tuesday, June 3, 2025, 08:00 Hrs [IST] Third World Network (TWN), a ...